Literature DB >> 15989210

Osteoporosis medications used by older African-American women: effects of socioeconomic status and psychosocial factors.

Christine G Unson1, Richard Fortinsky, Karen Prestwood, Susan Reisine.   

Abstract

This study examined the effects of socioeconomic status, knowledge and Health Belief Model variables on ever use of hormone therapy and other osteoporosis medications among older African-American women. One-hundred and two African-American women, 60 years old or older, randomly selected from Registers of Voters and a list of participants in educational activities of a university hospital, were interviewed in their homes. Data collected concerned knowledge of osteoporosis, Health Belief Model variables, and cues to action such as history of hysterectomy, personal and family history of cancer, bone mineral density testing, and discussion with a physician about osteoporosis. Socioeconomic status indicators included years of education and household income. The average respondent age was 71.1 years; 47% were current or previous users (ever users) of hormone therapy, and 11% were ever users of other osteoporosis medications. Knowledge of osteoporosis, (odds ratio = 1.4), Hormone therapy benefits, (odds ratio = 1.63), a hysterectomy (odds ratio = 4.35), and a family history of cancer (odds ratio = 4.0) increased the odds of ever using hormone therapy. Perceptions of susceptibility (odds ratio = 3.5) and discussion with a physician about osteoporosis (odds ratio = 6.4) increased odds of ever using other osteoporosis medications. Socioeconomic status mediated the effects of knowledge of osteoporosis on ever using hormone therapy. Efforts to promote bone health to older African-American women should focus primary efforts to increasing perceptions of susceptibility to fracture and persuading physicians to initiate discussions about fracture prevention with African-American patients before a fracture occurs.

Entities:  

Mesh:

Year:  2005        PMID: 15989210     DOI: 10.1007/s10900-005-3706-3

Source DB:  PubMed          Journal:  J Community Health        ISSN: 0094-5145


  39 in total

Review 1.  Hormone replacement therapy and the skin.

Authors:  M P Brincat
Journal:  Maturitas       Date:  2000-05-29       Impact factor: 4.342

2.  SES differentials in health by age and alternative indicators of SES.

Authors:  S Robert; J S House
Journal:  J Aging Health       Date:  1996-08

3.  Socioeconomic status and health among the aged in the United States and Germany: a comparative cross-sectional study.

Authors:  Olaf von dem Knesebeck; Günther Lüschen; William C Cockerham; Johannes Siegrist
Journal:  Soc Sci Med       Date:  2003-11       Impact factor: 4.634

4.  Mood symptoms and cognitive performance in women estrogen users and nonusers and men.

Authors:  Karen J Miller; Janet C Conney; Natalie L Rasgon; Lynn A Fairbanks; Gary W Small
Journal:  J Am Geriatr Soc       Date:  2002-11       Impact factor: 5.562

5.  Social learning theory and the Health Belief Model.

Authors:  I M Rosenstock; V J Strecher; M H Becker
Journal:  Health Educ Q       Date:  1988

6.  How well are community-living women treated for osteoporosis after hip fracture?

Authors:  S Bellantonio; R Fortinsky; K Prestwood
Journal:  J Am Geriatr Soc       Date:  2001-09       Impact factor: 5.562

7.  Health beliefs and attitudes toward the prevention of osteoporosis in older women.

Authors:  C Hsieh; K D Novielli; J J Diamond; D Cheruva
Journal:  Menopause       Date:  2001 Sep-Oct       Impact factor: 2.953

8.  Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study.

Authors:  K M Brett; J H Madans
Journal:  Am J Epidemiol       Date:  1997-03-15       Impact factor: 4.897

9.  Risk factors for hip fracture in black women. The Northeast Hip Fracture Study Group.

Authors:  J A Grisso; J L Kelsey; B L Strom; L A O'Brien; G Maislin; K LaPann; L Samelson; S Hoffman
Journal:  N Engl J Med       Date:  1994-06-02       Impact factor: 91.245

10.  The decision to accept treatment for osteoporosis following hip fracture: exploring the woman's perspective using a stage-of-change model.

Authors:  K F Mauck; M T Cuddihy; R T Trousdale; G R Pond; V S Pankratz; L J Melton
Journal:  Osteoporos Int       Date:  2002-07       Impact factor: 4.507

View more
  4 in total

1.  Correlates of use of antifracture therapy in older women with low bone mineral density.

Authors:  Kathryn M Ryder; Ronald I Shorr; Frances A Tylavsky; Andrew J Bush; Douglas C Bauer; Eleanor M Simonsick; Elsa S Strotmeyer; Tamara B Harris
Journal:  J Gen Intern Med       Date:  2006-06       Impact factor: 5.128

2.  Educational level and use of osteoporosis drugs in elderly men and women: a Swedish nationwide register-based study.

Authors:  J W Wastesson; G Ringbäck Weitoft; M G Parker; K Johnell
Journal:  Osteoporos Int       Date:  2012-02-21       Impact factor: 4.507

3.  Use of voter registration records to recruit a representative sample.

Authors:  Erika H Westling; Sarah E Hampson; Lisa A Strycker; Deborah J Toobert
Journal:  J Behav Med       Date:  2011-01-25

Review 4.  Bisphosphonate therapy for women with breast cancer and at high risk for osteoporosis.

Authors:  Gloria J Morris; Edith P Mitchell
Journal:  J Natl Med Assoc       Date:  2007-01       Impact factor: 1.798

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.